Scotia Capital’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $234K | Buy |
4,743
+138
| +3% | +$7.01K | ﹤0.01% | 824 |
|
|
2026
Q1 | $246K | Sell |
4,605
-778
| -14% | -$45.7K | ﹤0.01% | 813 |
|
|
2025
Q4 | $335K | Sell |
5,383
-1,048
| -16% | -$64.7K | ﹤0.01% | 727 |
|
|
2025
Q3 | $386K | Buy |
6,431
+1,302
| +25% | +$79.6K | ﹤0.01% | 715 |
|
|
2025
Q2 | $321K | Sell |
5,129
-4
| -0.1% | -$240 | ﹤0.01% | 707 |
|
|
2025
Q1 | $309K | Buy |
5,133
+628
| +14% | +$39K | ﹤0.01% | 699 |
|
|
2024
Q4 | $263K | Hold |
4,505
| – | – | ﹤0.01% | 731 |
|
|
2024
Q3 | $267K | Sell |
4,505
-184
| -4% | -$10.5K | ﹤0.01% | 714 |
|
|
2024
Q2 | $263K | Sell |
4,689
-37,726
| -89% | -$2.11M | ﹤0.01% | 707 |
|
|
2024
Q1 | $2.49M | Sell |
42,415
-2,614
| -6% | -$148K | 0.01% | 349 |
|
|
2023
Q4 | $2.43M | Buy |
45,029
+1,119
| +3% | +$54.7K | 0.02% | 329 |
|
|
2023
Q3 | $2.13M | Sell |
43,910
-684
| -2% | -$36.4K | 0.02% | 334 |
|
|
2023
Q2 | $2.52M | Buy |
44,594
+403
| +0.9% | +$22.2K | 0.02% | 311 |
|
|
2023
Q1 | $2.39M | Buy |
44,191
+2,546
| +6% | +$136K | 0.02% | 324 |
|
|
2022
Q4 | $2.19M | Sell |
41,645
-43
| -0.1% | -$2.18K | 0.02% | 337 |
|
|
2022
Q3 | $1.97M | Sell |
41,688
-27,216
| -39% | -$1.41M | 0.02% | 338 |
|
|
2022
Q2 | $3.48M | Sell |
68,904
-18,103
| -21% | -$987K | 0.03% | 273 |
|
|
2022
Q1 | $5.3M | Sell |
87,007
-1,270
| -1% | -$75.7K | 0.03% | 247 |
|
|
2021
Q4 | $5.81M | Buy |
88,277
+3,635
| +4% | +$233K | 0.04% | 234 |
|
|
2021
Q3 | $5.31M | Buy |
84,642
+14,658
| +21% | +$935K | 0.04% | 238 |
|
|
2021
Q2 | $4.21M | Sell |
69,984
-23,346
| -25% | -$1.35M | 0.03% | 270 |
|
|
2021
Q1 | $5.14M | Sell |
93,330
-4,176
| -4% | -$232K | 0.04% | 230 |
|
|
2020
Q4 | $5.32M | Buy |
97,506
+25,758
| +36% | +$1.35M | 0.05% | 203 |
|
|
2020
Q3 | $3.58M | Sell |
71,748
-1,902
| -3% | -$92.1K | 0.04% | 225 |
|
|
2020
Q2 | $3.25M | Buy |
73,650
+5,478
| +8% | +$234K | 0.05% | 201 |
|
|
2020
Q1 | $2.56M | Sell |
68,172
-336
| -0.5% | -$14.1K | 0.04% | 218 |
|
|
2019
Q4 | $3.02M | Buy |
68,508
+36,492
| +114% | +$1.53M | 0.03% | 238 |
|
|
2019
Q3 | $1.32M | Buy |
32,016
+300
| +0.9% | +$12.3K | 0.02% | 341 |
|
|
2019
Q2 | $1.27M | Buy |
31,716
+1,764
| +6% | +$66.8K | 0.02% | 358 |
|
|
2019
Q1 | $1.16M | Buy |
29,952
+300
| +1% | +$10.9K | 0.01% | 357 |
|
|
2018
Q4 | $987K | Buy |
29,652
+5,208
| +21% | +$180K | 0.01% | 357 |
|
|
2018
Q3 | $927K | Buy |
+24,444
| New | +$869K | 0.01% | 419 |
|
|
2018
Q1 | – | Sell |
-64,482
| Closed | -$1.86M | – | 730 |
|
|
2017
Q4 | $1.86M | Buy |
64,482
+672
| +1% | +$19.4K | 0.02% | 304 |
|
|
2017
Q3 | $1.78M | Buy |
+63,810
| New | +$1.77M | 0.03% | 296 |
|
Other funds holding IHI
AAS
Scotia Capital's IHI Position: Q2 2026 in Review
Scotia Capital increased its iShares US Medical Devices ETF (IHI) stake by 3% in Q2 2026, buying an estimated $7.01K and bringing the position to 4,743 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #824.
Scotia Capital first reported a position in IHI in Q3 2017 and has held it in 34 quarters since. The position peaked at $5.81M in Q4 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Scotia Capital held 4,743 shares of iShares US Medical Devices ETF worth $234K as of Q2 2026.
- Scotia Capital bought 138 iShares US Medical Devices ETF shares in Q2 2026, an estimated $7.01K.
- iShares US Medical Devices ETF made up ﹤0.01% of Scotia Capital's portfolio in Q2 2026, its #824 holding.
- Scotia Capital first reported a position in iShares US Medical Devices ETF in Q3 2017 and has held it in 34 quarters since.
- Scotia Capital's iShares US Medical Devices ETF position peaked at $5.81M in Q4 2021.
- 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.